- NHS North West Genomics v2.2.5

NHS North West Genomics - Local Development build (v2.2.5) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions

CodeSystem: NHS England Digital Genomic Test Services

Official URL: https://fhir.nhs.uk/CodeSystem/England-DigitalGenomicTestServices				Version: 2.2.5	Highlight text changes?
Active as of 2026-09-08					Computable Name: DigitalGenomicTestServices

The digital National Genomic Test Directory codes, rolled out as the Test Directory itself went digital - replacing the legacy R-code/M-code style codes in NHS England Genomic Test Code ($GTD, England-GenomicTestDirectory) for new/migrated indications. Two code types share this one system, distinguished by prefix:

TP (Test Package) codes replace the old clinical-indication concept - a package of related genomic tests grouped by clinical condition.
GT (Genomic/Genetic Test) codes identify a single specific laboratory investigation.

Refreshed from the Haematological Oncology (v1.1) and Cancer CNS (v2) national genomic test directories on 2026-09-08 - see ConceptMap-GenomicTestCodeToDigitalGenomicTestServices and ConceptMap-GenomicClinicalIndicationToDigitalGenomicTestServices for how these relate to the legacy codes they replace.

category is mostly file-derived (haem-onc v1.1 -> haematological-oncology, CNS v2 -> cancer) but not entirely - a handful of codes are curated by hand outside this notebook (e.g. TP401 "Chimerism Testing" -> chimerism) and preserved across reruns rather than re-derived; see notebook 14's own note on this for the full reasoning. test-method (GT codes only) comes straight from each source row's own "Test Method" column, refreshed fresh every run. No specialist-test-group here - neither source directory has an equivalent column.

This Code system is referenced in the definition of the following value sets:

Genomic Test Codes

Properties

This code system defines the following properties for its concepts

Name

Code

URI

Type

Description

Parent

parent

http://hl7.org/fhir/concept-properties#parent

code

The Test Package (TP) code(s) this Genomic Test (GT) code belongs to

category

https://fhir.nhs.uk/CodeSystem/England-DigitalGenomicTestServices#category

code

Which part of the National Genomic Test Directory this code belongs to: rare-and-inherited-disease, cancer, haematological-oncology, or chimerism

test-method

https://fhir.nhs.uk/CodeSystem/England-DigitalGenomicTestServices#test-method

string

The test method/technology used, from the source directory's own Test Method column (Genomic/Genetic Test (GT) codes only - a Test Package (TP) can bundle more than one technology)

Concepts

This case-sensitive code system https://fhir.nhs.uk/CodeSystem/England-DigitalGenomicTestServices provides a fragment that includes following codes:

Lvl	Code	Display	Parent	category	test-method
1	TP34	Acute Lymphoblastic Leukaemia - T cell		haematological-oncology
2	GT10	TAL1, 1p33 FISH - T-ALL	TP34	haematological-oncology	Targeted assay
2	GT31	MRD BCR::ABL1 - AML, ALL & CML	TP241, TP34, TP374, TP450	haematological-oncology	Targeted assay
2	GT52	JAK2, 9p24.1 FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT85	ABL1, 9q34 FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT183	WGS Germline & Tumour - T-ALL	TP34	haematological-oncology	Whole Genome Sequencing
2	GT200	Other FISH Targets - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT225	WGS Follow-up Germline - T-ALL	TP34	haematological-oncology	Whole Genome Sequencing
2	GT239	TLX1::, 10q24 FISH - T-ALL	TP34	haematological-oncology	Targeted assay
2	GT296	ABL2, 1q25 FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT301	KMT2A, 11q23 FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT303	BCR::ABL1 TKD Variants - AML, ALL & CML	TP241, TP34, TP374, TP450	haematological-oncology	Sequencing
2	GT329	Next Generation Sequencing Panel - Structural Variants - ALL	TP241, TP34	haematological-oncology	Sequencing
2	GT332	MRD Target Identification - T-ALL	TP34	haematological-oncology	Sequencing
2	GT350	Next Generation Sequencing Panel - Copy Number Variants - ALL	TP241, TP34	haematological-oncology	Sequencing
2	GT512	KMT2A::AFDN, t(6;11)(q27;q23) FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT527	SNP Array - T-ALL	TP34	haematological-oncology	Microarray
2	GT649	BCR::ABL1 multiplex - CML, ALL or AML	TP228, TP241, TP34, TP374, TP450	haematological-oncology	Targeted assay
2	GT673	MRD BCR::ABL1 Rare Transcripts - AML, ALL & CML	TP241, TP34, TP374, TP450	haematological-oncology	Targeted assay
2	GT687	WGS Tumour First - T-ALL	TP34	haematological-oncology	Whole Genome Sequencing
2	GT694	NUDT15, 13q14 Pharmacogenomic Test - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT739	Other RT-PCR Targets - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT844	KMT2A::MLLT3, t(9;11)(p21;q23) FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT849	Next Generation Sequencing Panel - Small Variants - ALL	TP241, TP34	haematological-oncology	Sequencing
2	GT985	Other MRD Targets - T-ALL	TP34	haematological-oncology	Targeted assay
2	GT1089	PDGFRA, 4q12 FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT1096	Karyotype - AML, ALL & CML	TP241, TP34, TP374, TP450	haematological-oncology	Chromosome analysis
2	GT1149	MRD Quantification - T-ALL	TP34	haematological-oncology	Targeted assay
2	GT1163	BCR::ABL1, t(9;22)(q34;q11) FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT1180	PDGFRB / CSF1R, 5q32 FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT1185	TPMT, 6p22 Pharmacogenomic Test - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT1191	KMT2A::AFF1, t(4;11)(q21;q23) FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT1300	KMT2A::ELL, t(11;19)(q23;p13.1) FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT1308	KMT2A::MLLT10, t(10;11)(p12;q23) FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
2	GT1309	KMT2A::MLLT1, t(11;19)(q23;p13.3) FISH - ALL	TP241, TP34	haematological-oncology	Targeted assay
1	TP58	Mature T Cell Neoplasms		haematological-oncology
2	GT59	TCL1A, 14q32 FISH - Mature T Cell Neoplasms	TP58	haematological-oncology	Targeted assay
2	GT256	IRF4/DUSP22, 6p25 FISH - Mature T Cell Neoplasms	TP58	haematological-oncology	Targeted assay
2	GT345	Chromosome 7 CNV FISH - Mature T Cell Neoplasms	TP58	haematological-oncology	Targeted assay
2	GT733	TP63, 3q28 FISH - Mature T Cell Neoplasms	TP58	haematological-oncology	Targeted assay
2	GT821	Next Generation Sequencing (DNA Based) Panel - Structural Variants - Mature T Cell Neoplasms	TP58	haematological-oncology	Sequencing
2	GT918	Karyotype - Mature B & T Cell Neoplasm	TP377, TP58	haematological-oncology	Chromosome analysis
2	GT999	WGS Germline & Tumour - ALK Positive Anaplastic Large Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1002	WGS Follow-up Germline - ALK Positive Anaplastic Large Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1008	WGS Tumour First - ALK Positive Anaplastic Large Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1146	TCR FISH - Mature T Cell Neoplasms	TP58	haematological-oncology	Targeted assay
2	GT1153	Next Generation Sequencing RNA Panel - Structural Variants - Mature T Cell Neoplasms	TP58	haematological-oncology	Sequencing
2	GT1279	Next Generation Sequencing Panel - Small Variants - Mature T Cell Neoplasms	TP58	haematological-oncology	Sequencing
2	GT1338	Other FISH Targets - Mature T cell neoplasms	TP58	haematological-oncology	Targeted assay
2	GT1352	WGS Germline & Tumour - Hepatosplenic T Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1353	WGS Follow-up Germline - T Cell NHL	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1358	WGS Tumour First - T Cell NHL	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1359	WGS Follow-up Germline - ALK Negative Anaplastic Large Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1361	WGS Tumour First - Hepatosplenic T Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1362	WGS Tumour First - ALK Negative Anaplastic Large Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1364	WGS Follow-up Germline - Hepatosplenic T Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1369	WGS Germline & Tumour - ALK Negative Anaplastic Large Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1372	WGS Follow-up Germline - NK Cell/Gamma-Delta T Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1376	WGS Germline & Tumour - NK Cell/Gamma-Delta T Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1384	WGS Tumour First - NK Cell/Gamma-Delta T Cell Lymphoma	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1385	ALK::NPM1, t(2;5)(p23;q35) FISH - Mature T Cell Neoplasms	TP58	haematological-oncology	Targeted assay
2	GT1386	WGS Germline & Tumour - T Cell NHL	TP58	haematological-oncology	Whole Genome Sequencing
2	GT1416	ALK, 2p23 FISH - Mature T Cell Neoplasms	TP58	haematological-oncology	Targeted assay
2	GT1422	Chromosome 8 CNV FISH - Mature T Cell Neoplasms	TP58	haematological-oncology	Targeted assay
1	TP62	Clonality Testing		haematological-oncology
2	GT39	T Cell Clonality Testing - Multiplex Sequencing	TP62	haematological-oncology	Sequencing
2	GT508	T Cell Clonality Testing - NGS	TP62	haematological-oncology	Sequencing
2	GT1408	B Cell Clonality Testing - NGS	TP62	haematological-oncology	Sequencing
2	GT1423	B Cell Clonality Testing - Multiplex Sequencing	TP62	haematological-oncology	Sequencing
1	TP126	Myeloma		haematological-oncology
2	GT40	IGH::FGFR3, t(4;14)(p16;q32) FISH - Myeloma	TP126	haematological-oncology	Targeted assay
2	GT75	Next Generation Sequencing Panel - Copy Number Variants - Myeloma	TP126	haematological-oncology	Sequencing
2	GT178	SNP Array - Myeloma	TP126	haematological-oncology	Microarray
2	GT187	IGH::CCND1, t(11;14)(q13;q32) FISH - Myeloma	TP126	haematological-oncology	Targeted assay
2	GT383	Chromosome 17 CNV FISH - Myeloma	TP126	haematological-oncology	Targeted assay
2	GT429	Next Generation Sequencing Panel - Small Variants - Myeloma	TP126	haematological-oncology	Sequencing
2	GT549	IGH::MAF, t(14;16)(q32;q23) FISH - Myeloma	TP126	haematological-oncology	Targeted assay
2	GT565	Other FISH Targets - Myeloma	TP126	haematological-oncology	Targeted assay
2	GT632	MYC, 8q24 FISH - Myeloma	TP126	haematological-oncology	Targeted assay
2	GT725	IGH, 14q32 FISH - Myeloma	TP126	haematological-oncology	Targeted assay
2	GT746	IGH::MAFB, t(14;20)(q32;q12) FISH - Myeloma	TP126	haematological-oncology	Targeted assay
2	GT855	CKS1B, 1q21 & CDKN2C, 1p32 CNV FISH - Myeloma	TP126	haematological-oncology	Targeted assay
2	GT890	IGH::CCND3, t(6;14)(p21;q32) FISH - Myeloma	TP126	haematological-oncology	Targeted assay
2	GT1274	Next Generation Sequencing Panel - Structural Variants - Myeloma	TP126	haematological-oncology	Sequencing
2	GT1277	Hyperdiploidy CNV FISH or MLPA - Myeloma	TP126	haematological-oncology	Targeted assay
1	TP171	Cystic renal disease		rare-and-inherited-disease
2	GT497	Cystic renal disease - WGS	TP171	rare-and-inherited-disease
1	TP182	Histiocytosis		haematological-oncology
2	GT35	WGS Tumour First - Histiocytosis	TP182	haematological-oncology	Whole Genome Sequencing
2	GT69	BRAF Hotspot (V600E) High Sensitivity - Histiocytosis	TP182	haematological-oncology	Targeted assay
2	GT426	BRAF, 7q34 FISH - Histiocytosis	TP182	haematological-oncology	Targeted assay
2	GT456	NTRK1, 1q23 FISH - Histiocytosis	TP182	haematological-oncology	Targeted assay
2	GT579	ALK, 2p23 FISH - Histiocytosis	TP182	haematological-oncology	Targeted assay
2	GT593	WGS Germline & Tumour - Histiocytosis	TP182	haematological-oncology	Whole Genome Sequencing
2	GT836	WGS Follow-up Germline - Histiocytosis	TP182	haematological-oncology	Whole Genome Sequencing
2	GT892	Next Generation Sequencing Panel - Small Variants - Histiocytosis	TP182	haematological-oncology	Sequencing
2	GT914	Next Generation Sequencing Panel - Structural Variants - Histiocytosis	TP182	haematological-oncology	Sequencing
1	TP202	Myelodysplastic Syndromes		haematological-oncology
2	GT128	WGS Follow-up Germline - MDS/MPN	TP202	haematological-oncology	Whole Genome Sequencing
2	GT172	MECOM, 3q21 FISH - MDS & MPN	TP202, TP228	haematological-oncology	Targeted assay
2	GT198	Chromosome 7 CNV FISH - MDS & MPN	TP202, TP228	haematological-oncology	Targeted assay
2	GT265	WGS Germline & Tumour - MDS/MPN	TP202	haematological-oncology	Whole Genome Sequencing
2	GT304	WGS Follow-up Germline - AA	TP202	haematological-oncology	Whole Genome Sequencing
2	GT397	Next Generation Sequencing Panel - Copy Number Variants - MDS	TP202	haematological-oncology	Sequencing
2	GT595	Chromosome 17 CNV FISH - MDS	TP202	haematological-oncology	Targeted assay
2	GT635	SNP Array - MDS	TP202	haematological-oncology	Microarray
2	GT701	Next Generation Sequencing Panel - Structural Variants - MDS	TP202	haematological-oncology	Sequencing
2	GT702	WGS Tumour First - JMML	TP202	haematological-oncology	Whole Genome Sequencing
2	GT889	WGS Tumour First - MDS/MPN	TP202	haematological-oncology	Whole Genome Sequencing
2	GT939	Other FISH Targets - MDS	TP202	haematological-oncology	Targeted assay
2	GT1023	WGS Follow-up Germline - MDS	TP202	haematological-oncology	Whole Genome Sequencing
2	GT1114	WGS Follow-up Germline - JMML	TP202	haematological-oncology	Whole Genome Sequencing
2	GT1224	Chromosome 5 CNV FISH - MDS & MPN	TP202, TP228	haematological-oncology	Targeted assay
2	GT1238	WGS Germline & Tumour - JMML	TP202	haematological-oncology	Whole Genome Sequencing
2	GT1248	Chromosome 8 CNV FISH - MDS & MPN	TP202, TP228	haematological-oncology	Targeted assay
2	GT1297	Next Generation Sequencing Panel - Small Variants - MDS	TP202	haematological-oncology	Sequencing
2	GT1302	Chromosome 20 CNV FISH - MDS	TP202	haematological-oncology	Targeted assay
2	GT1312	WGS Germline & Tumour - MDS	TP202	haematological-oncology	Whole Genome Sequencing
2	GT1340	WGS Tumour First - AA	TP202	haematological-oncology	Whole Genome Sequencing
2	GT1375	Karyotype - MDS	TP202	haematological-oncology	Chromosome analysis
2	GT1382	WGS Germline & Tumour - AA	TP202	haematological-oncology	Whole Genome Sequencing
2	GT1439	WGS Tumour First - MDS	TP202	haematological-oncology	Whole Genome Sequencing
1	TP228	Myeloproliferative Neoplasm		haematological-oncology
2	GT12	WGS Tumour First - Systemic mastocytosis	TP228	haematological-oncology	Whole Genome Sequencing
2	GT13	JAK2, 9q24 FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT100	SNP Array - MPN	TP228	haematological-oncology	Microarray
2	GT147	FGFR1, 8p11 FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT152	ABL1, 9q34 FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT246	KIT Hotspot (D816) High Sensitivity - Systemic Mastocytosis	TP228	haematological-oncology	Targeted assay
2	GT326	MPL Hotspot (exon 10) - MPN	TP228	haematological-oncology	Targeted assay
2	GT355	Chromosome 17 CNV FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT373	PDGFRA, 4q21 FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT386	Next Generation Sequencing Panel - Structural Variants - MPN	TP228	haematological-oncology	Sequencing
2	GT468	FIP1L1::PDGFRA, 4q12 FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT543	WGS Tumour First - MPN	TP228	haematological-oncology	Whole Genome Sequencing
2	GT552	WGS Germline & Tumour - MPN	TP228	haematological-oncology	Whole Genome Sequencing
2	GT614	Other RT-PCR Targets - MPN	TP228	haematological-oncology	Targeted assay
2	GT662	MRD FIP1L1::PDGFRA - MPN	TP228	haematological-oncology	Targeted assay
2	GT699	FIP1L1::PDGFRA, 4q12 FISH or RT-PCR - MPN	TP228	haematological-oncology	Targeted assay
2	GT717	Next Generation Sequencing Panel - Small Variants (Limited) - MPN	TP228	haematological-oncology	Sequencing
2	GT736	Next Generation Sequencing Panel - Copy Number Variants - MPN	TP228	haematological-oncology	Sequencing
2	GT763	BCR::ABL1, t(9;22)(q34;q11) FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT818	PCM1::JAK2, t(8;9)(p22;q24) FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT819	Next Generation Sequencing Panel - Small Variants - MPN	TP228	haematological-oncology	Sequencing
2	GT965	JAK2 Hotspot (exon 12) - MPN	TP228	haematological-oncology	Targeted assay
2	GT986	JAK2 Hotspot (V617F) - MPN	TP228	haematological-oncology	Targeted assay
2	GT1015	Chromosome 12 CNV FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT1029	WGS Follow-up Germline - Systemic Mastocytosis	TP228	haematological-oncology	Whole Genome Sequencing
2	GT1042	CALR Hotspot (exon 9) - MPN	TP228	haematological-oncology	Targeted assay
2	GT1063	WGS Germline & Tumour - Systemic mastocytosis	TP228	haematological-oncology	Whole Genome Sequencing
2	GT1211	Other FISH Targets - MPN	TP228	haematological-oncology	Targeted assay
2	GT1233	Karyotype - MPN	TP228	haematological-oncology	Chromosome analysis
2	GT1236	WGS Follow-up Germline - MPN	TP228	haematological-oncology	Whole Genome Sequencing
2	GT1282	ETV6::PDGFRB, t(5;12)(q33;p13) FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT1355	PDGFRB, 5q32 FISH - MPN	TP228	haematological-oncology	Targeted assay
2	GT1497	MRD JAK2 Hotspot (V617F) - MPN	TP228	haematological-oncology	Targeted assay
2	GT172	MECOM, 3q21 FISH - MDS & MPN
2	GT198	Chromosome 7 CNV FISH - MDS & MPN
2	GT649	BCR::ABL1 multiplex - CML, ALL or AML
2	GT1224	Chromosome 5 CNV FISH - MDS & MPN
2	GT1248	Chromosome 8 CNV FISH - MDS & MPN
1	TP241	Acute Lymphoblastic Leukaemia - B cell		haematological-oncology
2	GT7	CRLF2, Xp22/Yp11 FISH - ALL	TP241	haematological-oncology	Targeted assay
2	GT56	IGH, 14q32 FISH - B-ALL	TP241	haematological-oncology	Targeted assay
2	GT160	Ploidy Status CNV FISH - ALL	TP241	haematological-oncology	Targeted assay
2	GT214	Other MRD Targets - B-ALL	TP241	haematological-oncology	Targeted assay
2	GT254	WGS Tumour First - Acute leukaemia other	TP241	haematological-oncology	Whole Genome Sequencing
2	GT295	SNP Array - B-ALL	TP241	haematological-oncology	Microarray
2	GT315	TCF3, 19p13 FISH - ALL	TP241	haematological-oncology	Targeted assay
2	GT467	WGS Germline & Tumour - B-ALL	TP241	haematological-oncology	Whole Genome Sequencing
2	GT483	IGL::MYC, t(8;22)(q24;q11) FISH - ALL	TP241	haematological-oncology	Targeted assay
2	GT546	IGK::MYC, t(2;8)(p12;q24) FISH	TP241	haematological-oncology	Targeted assay
2	GT548	ETV6::RUNX1, t(12;21)(p13;q22) & iAMP21 FISH - B-ALL	TP241	haematological-oncology	Targeted assay
2	GT577	ETV6::RUNX1, t(12;21)(p13;q22) RT-PCR - ALL	TP241	haematological-oncology	Targeted assay
2	GT670	WGS Germline & Tumour - Acute leukaemia other	TP241	haematological-oncology	Whole Genome Sequencing
2	GT723	BCL6, 3q27 FISH - ALL	TP241	haematological-oncology	Targeted assay
2	GT729	IGH::MYC, t(8;14)(q34;q32) FISH - ALL	TP241	haematological-oncology	Targeted assay
2	GT738	MRD Target Identification - B-ALL	TP241	haematological-oncology	Sequencing
2	GT756	MYC, 8q24 FISH - ALL	TP241	haematological-oncology	Targeted assay
2	GT781	WGS Tumour First - B-ALL	TP241	haematological-oncology	Whole Genome Sequencing
2	GT825	WGS Follow-up Germline - Acute Leukaemia Other	TP241	haematological-oncology	Whole Genome Sequencing
2	GT874	TCF3::PBX1, t(1;19)(q23;p13) & TCF3::HLF, t(17;19)(q22;p13) FISH - ALL	TP241	haematological-oncology	Targeted assay
2	GT1050	WGS Follow-up Germline - B-ALL	TP241	haematological-oncology	Whole Genome Sequencing
2	GT1052	BCL2, 18q21 FISH - ALL	TP241	haematological-oncology	Targeted assay
2	GT1247	MRD Quantification - B-ALL	TP241	haematological-oncology	Targeted assay
2	GT31	MRD BCR::ABL1 - AML, ALL & CML
2	GT52	JAK2, 9p24.1 FISH - ALL
2	GT85	ABL1, 9q34 FISH - ALL
2	GT200	Other FISH Targets - ALL
2	GT296	ABL2, 1q25 FISH - ALL
2	GT301	KMT2A, 11q23 FISH - ALL
2	GT303	BCR::ABL1 TKD Variants - AML, ALL & CML
2	GT329	Next Generation Sequencing Panel - Structural Variants - ALL
2	GT350	Next Generation Sequencing Panel - Copy Number Variants - ALL
2	GT512	KMT2A::AFDN, t(6;11)(q27;q23) FISH - ALL
2	GT649	BCR::ABL1 multiplex - CML, ALL or AML
2	GT673	MRD BCR::ABL1 Rare Transcripts - AML, ALL & CML
2	GT694	NUDT15, 13q14 Pharmacogenomic Test - ALL
2	GT739	Other RT-PCR Targets - ALL
2	GT844	KMT2A::MLLT3, t(9;11)(p21;q23) FISH - ALL
2	GT849	Next Generation Sequencing Panel - Small Variants - ALL
2	GT1089	PDGFRA, 4q12 FISH - ALL
2	GT1096	Karyotype - AML, ALL & CML
2	GT1163	BCR::ABL1, t(9;22)(q34;q11) FISH - ALL
2	GT1180	PDGFRB / CSF1R, 5q32 FISH - ALL
2	GT1185	TPMT, 6p22 Pharmacogenomic Test - ALL
2	GT1191	KMT2A::AFF1, t(4;11)(q21;q23) FISH - ALL
2	GT1300	KMT2A::ELL, t(11;19)(q23;p13.1) FISH - ALL
2	GT1308	KMT2A::MLLT10, t(10;11)(p12;q23) FISH - ALL
2	GT1309	KMT2A::MLLT1, t(11;19)(q23;p13.3) FISH - ALL
1	TP245	Haematological Tumours - Exhausted SOC		haematological-oncology
2	GT88	WGS Tumour First - exhausted SOC	TP245	haematological-oncology	Whole Genome Sequencing
2	GT104	WGS Germline & Tumour - exhausted SOC	TP245	haematological-oncology	Whole Genome Sequencing
2	GT1076	WGS Follow-up Germline - exhausted SOC	TP245	haematological-oncology	Whole Genome Sequencing
1	TP374	Chronic Myeloid Leukaemia		haematological-oncology
2	GT71	Chromosome 19 CNV FISH - CML	TP374	haematological-oncology	Targeted assay
2	GT73	Chromosome 7 CNV FISH - CML	TP374	haematological-oncology	Targeted assay
2	GT99	Next Generation Sequencing Panel - Structural Variants - CML	TP374	haematological-oncology	Sequencing
2	GT478	KMT2A, 11q23 FISH - CML	TP374	haematological-oncology	Targeted assay
2	GT538	WGS Germline & Tumour - CML	TP374	haematological-oncology	Whole Genome Sequencing
2	GT690	MECOM, 3q21 FISH - CML	TP374	haematological-oncology	Targeted assay
2	GT1034	Chromosome 8 CNV FISH - CML	TP374	haematological-oncology	Targeted assay
2	GT1193	Other FISH Targets - CML	TP374	haematological-oncology	Targeted assay
2	GT1265	SNP Array - CML	TP374	haematological-oncology	Microarray
2	GT1345	Chromosome 17 CNV FISH - CML	TP374	haematological-oncology	Targeted assay
2	GT1357	WGS Follow-up Germline - CML	TP374	haematological-oncology	Whole Genome Sequencing
2	GT1371	BCR::ABL1, t(9;22)(q34;q11) FISH - CML	TP374	haematological-oncology	Targeted assay
2	GT1373	WGS Tumour First - CML	TP374	haematological-oncology	Whole Genome Sequencing
2	GT1414	Next Generation Sequencing Panel - Copy Number Variant - CML	TP374	haematological-oncology	Sequencing
2	GT1424	Chromosome 5 CNV FISH - CML	TP374	haematological-oncology	Targeted assay
2	GT1426	Next Generation Sequencing Panel - Small Variant - CML	TP374	haematological-oncology	Sequencing
2	GT31	MRD BCR::ABL1 - AML, ALL & CML
2	GT303	BCR::ABL1 TKD Variants - AML, ALL & CML
2	GT649	BCR::ABL1 multiplex - CML, ALL or AML
2	GT673	MRD BCR::ABL1 Rare Transcripts - AML, ALL & CML
2	GT1096	Karyotype - AML, ALL & CML
1	TP377	Mature B Cell Neoplasms		haematological-oncology
2	GT50	Next Generation Sequencing RNA Panel - Structural Variants - Mature B Cell Neoplasms	TP377	haematological-oncology	Sequencing
2	GT120	MALT1, 18q21 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT267	Next Generation Sequencing Panel - Small Variants - Mature B Cell Neoplasms	TP377	haematological-oncology	Sequencing
2	GT272	MYD88 Hotspot (L265P Variants) - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT306	Next Generation Sequencing Panel - Copy Number Variants - Mature B Cell Neoplasms	TP377	haematological-oncology	Sequencing
2	GT312	IGL::MYC, t(8;22)(q24;q11) FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT321	BRAF Hotspot (V600E Variants) - Hairy Cell Leukaemia	TP377	haematological-oncology	Targeted assay
2	GT369	IRF4, 6p25 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT414	EZH2, 7q36 CNV FISH - Mature B Cell Neoplams	TP377	haematological-oncology	Targeted assay
2	GT444	SNP Array - Mature B Cell Neoplasms	TP377	haematological-oncology	Microarray
2	GT479	Chromosome 11q CNV FISH - B Cell Lymphoma with 11q Aberration	TP377	haematological-oncology	Targeted assay
2	GT534	REL, 2p16 CNV FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT576	MYC::IGH, t(8;14)(q34;q32) FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT613	BCL2, 18q21 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT637	CCND2, 12p13 FISH - Mantle Cell Lymphoma	TP377	haematological-oncology	Targeted assay
2	GT646	IGH::BCL2, t(14;18)(q32;q21) FISH - Follicular Lymphoma	TP377	haematological-oncology	Targeted assay
2	GT664	IGK::MYC, t(2;8)(p12;q24) FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT665	Other FISH Targets - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT779	BCL10, 1p22 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT795	Next Generation Sequencing (DNA Based) Panel - Structural Variants - Mature B Cell Neoplasms	TP377	haematological-oncology	Sequencing
2	GT852	IGH, 14q32 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT868	CCND1, 11q13 FISH - Mantle Cell Lymphoma	TP377	haematological-oncology	Targeted assay
2	GT1007	FOXP1, 3p13 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT1253	IGHV hypermutation (Multiplex Sequencing) - Hairy Cell Leukaemia	TP377	haematological-oncology	Sequencing
2	GT1285	BCL6, 3q27 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT1337	CD79B Hotspot (Y196 Variants) - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT1339	WGS Germline & Tumour - B Cell Lymphoma with 11q Aberration	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1341	WGS Germline & Tumour - B Cell Lymphoma with IRF4 Rearrangement	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1342	WGS Germline & Tumour - Follicular Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1343	WGS Follow-up Germline - Follicular lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1344	WGS Germline & Tumour - Marginal Zone Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1347	WGS Germline & Tumour - High Grade Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1348	CIITA, 16p13 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT1349	WGS Tumour First - Burkitt Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1350	WGS Germline & Tumour - Burkitt Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1351	WGS Follow-up Germline - High Grade Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1354	ALK, 2p23 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT1356	WGS Germline & Tumour - Low Grade Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1360	WGS Tumour First - ALK Positive Large B Cell Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1363	WGS Follow-up Germline - B Cell Lymphoma with 11q Aberration	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1365	WGS Follow-up Germline - Marginal Zone Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1366	WGS Follow-up Germline - Low Grade Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1367	WGS Follow-up Germline - B Cell Lymphoma with IRF4 Rearrangement	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1377	WGS Tumour First - Low Grade Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1378	WGS Germline & Tumour - ALK Positive Large B Cell Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1379	WGS Tumour First - Follicular Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1380	IGHV Hypermutation (NGS) - Hairy Cell Leukaemia	TP377	haematological-oncology	Sequencing
2	GT1381	WGS Germline & Tumour - Primary Mediastinal B Cell Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1383	WGS Follow-up Germline - ALK Positive Large B Cell Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1387	WGS Follow-up Germline - Primary Mediastinal B Cell Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1388	WGS Follow-up Germline - Burkitt Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1389	WGS Tumour First - Marginal Zone Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1390	WGS Tumour First - B Cell Lymphoma with 11q Aberration	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1391	WGS Tumour First - Primary Mediastinal B Cell Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1392	WGS Tumour First - B Cell Lymphoma with IRF4 Rearrangement	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1393	WGS Tumour First - High Grade Lymphoma	TP377	haematological-oncology	Whole Genome Sequencing
2	GT1394	MYC, 8q24 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT1404	CD274 / PDCD1LG2, 9p24 FISH - Mature B Cell Neoplasms	TP377	haematological-oncology	Targeted assay
2	GT1407	IGH::CCND1, t(11;14)(q13;q32) FISH - Mantle Cell Lymphoma	TP377	haematological-oncology	Targeted assay
2	GT918	Karyotype - Mature B & T Cell Neoplasm
1	TP401	Chimerism Testing		chimerism
2	GT1335	Chimerism by STR Testing - Post Solid Organ Transplant	TP401	chimerism	Targeted assay
2	GT1336	Chimerism by XY FISH - Post Solid Organ Transplant	TP401	chimerism	Targeted assay
2	GT1368	Chimerism by STR Testing - Post Stem Cell Transplant	TP401	chimerism	Targeted assay
2	GT1370	Chimerism by XY FISH - Post Stem Cell Transplant	TP401	chimerism	Targeted assay
1	TP450	Acute Myeloid Leukaemia		haematological-oncology
2	GT14	Chromosome 12 CNV FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT17	SNP Array - AML	TP450	haematological-oncology	Microarray
2	GT24	WGS Tumour First - AML	TP450	haematological-oncology	Whole Genome Sequencing
2	GT61	DEK::NUP214, t(6;9)(p22;q34) FISH or RT-PCR - AML	TP450	haematological-oncology	Targeted assay
2	GT74	NUP98::NSD1, t(5;11)(q35;p15.5) FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT101	RUNX1::RUNX1T1, t(8;21)(q22;q22) FISH or RT-PCR - AML	TP450	haematological-oncology	Targeted assay
2	GT112	RBM15::MRTFA, t(1;22)(p13;q13) FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT133	PML::RARA, t(15;17)(q24;q21) FISH or RT-PCR - AML	TP450	haematological-oncology	Targeted assay
2	GT157	GATA2::MECOM, inv(3)(q21q26) FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT180	NPM1::MLF1, t(3;5)(q25;q34) FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT185	Next Generation Sequencing Panel - Structural Variants - AML	TP450	haematological-oncology	Sequencing
2	GT253	Next Generation Sequencing Panel - Small Variants - AML	TP450	haematological-oncology	Sequencing
2	GT258	MLLT3::KMT2A, t(9;11)(p21;q23) & other KMT2A rearrangements FISH or RT-PCR - AML	TP450	haematological-oncology	Targeted assay
2	GT275	CBFB::MYH11, inv(16)(p13.1q22) FISH or RT-PCR - AML	TP450	haematological-oncology	Targeted assay
2	GT289	CBFA2T3::GLIS2, inv(16)(p13.3q24.3) FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT343	MRD RUNX1::RUNX1T1 - AML	TP450	haematological-oncology	Targeted assay
2	GT351	Other RT-PCR Targets - AML	TP450	haematological-oncology	Targeted assay
2	GT475	MRD PML::RARA - AML	TP450	haematological-oncology	Targeted assay
2	GT494	IDH1 Hotspot (R132 Variants) - AML	TP450	haematological-oncology	Targeted assay
2	GT517	WGS Germline & Tumour - BPDCN	TP450	haematological-oncology	Whole Genome Sequencing
2	GT533	FLT3 ITD Targeted Assay - AML	TP450	haematological-oncology	Targeted assay
2	GT629	Next Generation Sequencing Panel - Copy Number Variants - AML	TP450	haematological-oncology	Sequencing
2	GT656	MNX1::ETV6, t(7;12)(q36;p13) FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT700	Chromosome 7 CNV FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT703	Other MRD Targets - AML	TP450	haematological-oncology	Targeted assay
2	GT716	Other FISH Targets - AML	TP450	haematological-oncology	Targeted assay
2	GT726	WGS Germline & Tumour - AML	TP450	haematological-oncology	Whole Genome Sequencing
2	GT802	WGS Follow-up Germline - AML	TP450	haematological-oncology	Whole Genome Sequencing
2	GT870	MRD CBFB::MYH11 - AML	TP450	haematological-oncology	Targeted assay
2	GT879	WGS Tumour First - BPDCN	TP450	haematological-oncology	Whole Genome Sequencing
2	GT916	FLT3 TKD Targeted Assay - AML	TP450	haematological-oncology	Targeted assay
2	GT921	NPM1 Hotspot (exon 12) - AML	TP450	haematological-oncology	Targeted assay
2	GT1033	BCR::ABL1, t(9;22)(q34;q11) FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT1062	MRD NPM1 - AML	TP450	haematological-oncology	Targeted assay
2	GT1064	Chromosome 17 CNV FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT1166	NUP98, 11p15 FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT1221	WGS Follow-up Germline - BPDCN	TP450	haematological-oncology	Whole Genome Sequencing
2	GT1228	MRD NPM1 Rare Transcripts - AML	TP450	haematological-oncology	Targeted assay
2	GT1294	Chromosome 5 CNV FISH - AML	TP450	haematological-oncology	Targeted assay
2	GT31	MRD BCR::ABL1 - AML, ALL & CML
2	GT303	BCR::ABL1 TKD Variants - AML, ALL & CML
2	GT649	BCR::ABL1 multiplex - CML, ALL or AML
2	GT673	MRD BCR::ABL1 Rare Transcripts - AML, ALL & CML
2	GT1096	Karyotype - AML, ALL & CML
1	TP533	Chronic Lymphocytic Leukaemia		haematological-oncology
2	GT231	Chromosome 11 CNV FISH - CLL	TP533	haematological-oncology	Targeted assay
2	GT338	Chromosome 13 CNV FISH - CLL	TP533	haematological-oncology	Targeted assay
2	GT551	IGHV Hypermutation (Multiplex Sequencing) - CLL	TP533	haematological-oncology	Sequencing
2	GT923	Chromosome 17 CNV FISH - CLL	TP533	haematological-oncology	Targeted assay
2	GT926	Other FISH Targets - CLL	TP533	haematological-oncology	Targeted assay
2	GT929	Next Generation Sequencing Panel - Copy Number Variants - CLL	TP533	haematological-oncology	Sequencing
2	GT935	SNP Array - CLL	TP533	haematological-oncology	Microarray
2	GT1181	IGHV Hypermutation (NGS) - CLL	TP533	haematological-oncology	Sequencing
2	GT1209	Next Generation Sequencing Panel - Small Variants - CLL	TP533	haematological-oncology	Sequencing
2	GT1281	Chromosome 12 CNV FISH - CLL	TP533	haematological-oncology	Targeted assay
1	TP604	Embryonal tumours of the CNS		cancer
2	GT27	MYC rearrangement FISH	TP604, TP640	cancer	Targeted assay
2	GT131	BCOR CNV FISH	TP604	cancer	Targeted assay
2	GT217	Genome-wide DNA Methylation Profiling	TP604, TP613, TP622, TP623, TP624, TP625, TP640	cancer	Targeted assay
2	GT236	BRAF rearrangement FISH	TP604, TP640	cancer	Targeted assay
2	GT431	NTRK - Multi-target NGS panel - structural variants	TP604, TP613, TP622, TP624, TP640	cancer	Sequencing
2	GT453	RELA rearrangement FISH	TP604, TP640	cancer	Targeted assay
2	GT583	YAP1 rearrangement FISH	TP604, TP640	cancer	Targeted assay
2	GT592	BRAF::KIAA1549 rearrangement	TP604, TP640	cancer	Targeted assay
2	GT634	MYCN CNV FISH	TP604, TP640	cancer	Targeted assay
2	GT777	BCOR rearrangement FISH	TP604	cancer	Targeted assay
2	GT790	MYC CNV FISH	TP604, TP640	cancer	Targeted assay
2	GT854	SNP Array	TP604, TP625	cancer	Microarray
2	GT913	ALK rearrangement FISH	TP604	cancer	Targeted assay
2	GT943	Embryonal Tumours WGS - Paediatric and Adult	TP604	cancer	Whole Genome Sequencing
2	GT1012	PTEN CNV FISH	TP604, TP640	cancer	Targeted assay
2	GT1258	TP53 deletion CNV FISH	TP604	cancer	Targeted assay
2	GT1280	MN1 rearrangement	TP604, TP640	cancer	FISH
2	GT1333	Structural variant, not otherwise specified - Targeted Variant Test	TP604, TP640	cancer	Targeted assay
2	GT1334	Small nucleotide variant , not otherwise specified - Targeted Variant Test	TP604, TP613, TP622, TP640	cancer	Targeted assay
2	GT1346	Copy number variant, not otherwise specified - Targeted Variant Test	TP604, TP622, TP640	cancer	Targeted assay
2	GT1411	Embryonal Tumours Differential Diagnosis-NGS Panel SNV and CNV	TP604	cancer	Sequencing
2	GT1413	Embryonal Tumours Differential Diagnosis-NGS Panel Structural Variant	TP604	cancer	Sequencing
1	TP613	Meningiomas		cancer
2	GT259	Meningioma WGS - Paediatric and Adult	TP613	cancer	Whole Genome Sequencing
2	GT1420	Meningiomas Differential Diagnosis-NGS Panel SNV and CNV	TP613	cancer	Sequencing
2	GT217	Genome-wide DNA Methylation Profiling
2	GT431	NTRK - Multi-target NGS panel - structural variants
2	GT1334	Small nucleotide variant , not otherwise specified - Targeted Variant Test
1	TP622	Tumours of the Sellar Region and Pituitary Tumours		cancer
2	GT944	MGMT promoter hypermethylation - methylation specific PCR	TP622, TP625, TP640	cancer	Targeted assay
2	GT1049	EGFR CNV FISH	TP622, TP640	cancer	Targeted assay
2	GT1405	Tumours of the Sellar Region and Pituitary Tumours Differential Diagnosis-NGS Panel SNV and CNV	TP622	cancer	Sequencing
2	GT1433	Tumours of the Sellar Region and Pituitary Tumours WGS - Paediatric and Adult	TP622	cancer	Whole Genome Sequencing
2	GT217	Genome-wide DNA Methylation Profiling
2	GT431	NTRK - Multi-target NGS panel - structural variants
2	GT1334	Small nucleotide variant , not otherwise specified - Targeted Variant Test
2	GT1346	Copy number variant, not otherwise specified - Targeted Variant Test
1	TP623	Cranial and Paraspinal Nerve Tumours		cancer
2	GT1434	Cranial and paraspinal nerve tumours Differential - NGS Panel SNV and CNV	TP623	cancer	Sequencing
2	GT1435	Cranial and paraspinal nerve tumours Differential - NGS Panel Structural Variant	TP623	cancer	Sequencing
2	GT1436	Cranial and paraspinal nerve tumours WGS- Paediatric and Adult	TP623	cancer	Whole Genome Sequencing
2	GT217	Genome-wide DNA Methylation Profiling
1	TP624	Choroid Plexus Tumours		cancer
2	GT1427	Choroid plexus tumours - NGS Panel SNV and CNV	TP624	cancer	Sequencing
2	GT1428	Choroid plexus tumours WGS - Paediatric and Adult	TP624	cancer	Whole Genome Sequencing
2	GT217	Genome-wide DNA Methylation Profiling
2	GT431	NTRK - Multi-target NGS panel - structural variants
1	TP625	CNS of uncertain differentiation (NOS) and Rare Tumours		cancer
2	GT1429	Tumours of the CNS NOS including Rare tumours Differential Diagnosis-NGS Panel SNV and CNV	TP625	cancer	Sequencing
2	GT1430	Tumours of the CNS NOS including Rare tumours Differential Diagnosis-NGS Panel Structural Variant	TP625	cancer	Sequencing
2	GT1431	CNS of uncertain differentiation (NOS) and Rare Tumours WGS - Paediatric and Adult	TP625	cancer	Whole Genome Sequencing
2	GT217	Genome-wide DNA Methylation Profiling
2	GT854	SNP Array
2	GT944	MGMT promoter hypermethylation - methylation specific PCR
1	TP640	Gliomas, Glioneuronal Tumours, and Neuronal tumours		cancer
2	GT6	Small variant (IDH2)	TP640	cancer	Targeted assay
2	GT237	EWSR1 rearrangement FISH	TP640	cancer	Targeted assay
2	GT279	1p19q CNV FISH	TP640	cancer	Targeted assay
2	GT353	CDKN2A CNV FISH	TP640	cancer	Targeted assay
2	GT720	Neurological Tumours-EGFRvIII-RT-PCR	TP640	cancer	Targeted assay
2	GT778	MYB rearrangement	TP640	cancer	FISH
2	GT1129	CDKN2B CNV FISH	TP640	cancer	Targeted assay
2	GT1138	MYBL1 rearrangement	TP640	cancer	FISH
2	GT1260	Ependymal Tumours Differential Diagnosis-NGS Panel SNV and CNV	TP640	cancer	Sequencing
2	GT1317	Small variant (IDH1)	TP640	cancer	Targeted assay
2	GT1332	ZFTA rearrangements FISH	TP640	cancer	Targeted assay
2	GT1403	Gliomas, Glioneuronal Tumours, and Neuronal tumours Differential Diagnosis-NGS Panel SNV and CNV	TP640	cancer	Sequencing
2	GT1415	Gliomas, Glioneuronal Tumours, and Neuronal tumours Differential Diagnosis-NGS Panel Structural Variants	TP640	cancer	Sequencing
2	GT1418	Ependymal Tumours Differential Diagnosis-NGS Panel Structural Variants	TP640	cancer	Sequencing
2	GT1432	Gliomas, Glioneuronal Tumours, and Neuronal tumours WGS - Paediatric and Adult	TP640	cancer	Whole Genome Sequencing
2	GT27	MYC rearrangement FISH
2	GT217	Genome-wide DNA Methylation Profiling
2	GT236	BRAF rearrangement FISH
2	GT431	NTRK - Multi-target NGS panel - structural variants
2	GT453	RELA rearrangement FISH
2	GT583	YAP1 rearrangement FISH
2	GT592	BRAF::KIAA1549 rearrangement
2	GT634	MYCN CNV FISH
2	GT790	MYC CNV FISH
2	GT944	MGMT promoter hypermethylation - methylation specific PCR
2	GT1012	PTEN CNV FISH
2	GT1049	EGFR CNV FISH
2	GT1280	MN1 rearrangement
2	GT1333	Structural variant, not otherwise specified - Targeted Variant Test
2	GT1334	Small nucleotide variant , not otherwise specified - Targeted Variant Test
2	GT1346	Copy number variant, not otherwise specified - Targeted Variant Test

Description of the above table(s).